microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway.
about
MiRNA profiling of gastrointestinal stromal tumors by next-generation sequencingMiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancerMicroRNAs and Gastrointestinal Stromal Tumor.MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor.Small Molecules in Rare Tumors: Emerging Role of MicroRNAs in GIST.Combination of Imatinib Mesylate and AKT Inhibitor Provides Synergistic Effects in Preclinical Study of Gastrointestinal Stromal Tumor.
P2860
Q33913895-6AFE6AC1-7536-417F-8303-139B1DE9F25AQ35919064-7D11107E-259B-40CC-A66B-64EBD2AE6EDDQ37702680-5644D234-1EE2-4C47-B2F7-91FEA950CE56Q38667013-92F4A836-EE45-44FE-A306-FA0EC5C19807Q38715517-7236ED87-6429-4D14-8A1F-8449B5686684Q38788295-4461A8BF-891F-4F33-A8BA-2FF7512F2FB9Q48132734-0746EE7E-B740-4F76-9EE0-FBDD29496BE2Q48644058-40E5C9AD-F82C-4DAB-9838-AAA5636CA184
P2860
microRNA-218 increase the sensitivity of gastrointestinal stromal tumor to imatinib through PI3K/AKT pathway.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
microRNA-218 increase the sens ...... inib through PI3K/AKT pathway.
@en
microRNA-218 increase the sens ...... inib through PI3K/AKT pathway.
@nl
type
label
microRNA-218 increase the sens ...... inib through PI3K/AKT pathway.
@en
microRNA-218 increase the sens ...... inib through PI3K/AKT pathway.
@nl
prefLabel
microRNA-218 increase the sens ...... inib through PI3K/AKT pathway.
@en
microRNA-218 increase the sens ...... inib through PI3K/AKT pathway.
@nl
P2093
P2860
P1476
microRNA-218 increase the sens ...... inib through PI3K/AKT pathway.
@en
P2093
Sichang Zheng
Zhengting Wang
P2860
P2888
P304
P356
10.1007/S10238-014-0280-Y
P577
2014-04-05T00:00:00Z